fda compounding glp-1 enforcement news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Managing Compounded GLP-1 Medications: A

The survival benefit appeared stronger versus insulin or metformin, but less so when compared with SGLT2 inhibitors, Vukasinov said

Discuss your current diabetes control if you have type 2 diabetes

Until formal studies confirm long-term outcomes, it remains an exciting but exploratory option in the world of skin boosters

Read More

Disord Fluid Electrolyte Metabol 52:8092 Acknowledgements The authors gratefully acknowledge the patients whose cases are presented in this publication for their gracious consent

Combining GLP-1 with other treatments Some patients explore combining their GLP-1 medication with other treatments for enhanced results